Aim-To evaluate the haemopoietic function ofbone marrow blood forming cells in human myelodysplastic syndromes (MDS) by silver staining of nucleolar organiser regions (AgNORs). Methods-Nucleoli were investigated in bone marrow blast cells and in erythroid, granulocytic, and megakaryocytic cells from 12 haematologically healthy subjects, and from 26 patients with MDS, including 14 with refractory anaemia (RA), nine with RA with excess blasts (RAEB), and three with RAEB in transformation (RAEB-t). The investigation was performed before treatment using a one step silver staining method. In each case 50 to 100 blasts, promyelocytes, myelocytes, immature (pronormoblastic and basophilic normoblastic) and mature (polychromatic normoblastic) erythroid elements, and megakaryocytes were evaluated for the mean numbers of nucleoli and AgNORs per nucleus. Student's t test was used to compare the patient and control groups. Other statistical analyses were carried out by the computer assisted "HEMA" system. Results-Compared with controls, the number of AgNORs in blasts, promyelocytes, immature erythroid elements, and megakaryocytes was decreased, whereas in myelocytes and polychromatic normoblasts it was similar. There was also a difference in the AgNOR scores in blood forming cells from patients with RAEB/ RAEB-t v RA.
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Conclusions

Patients and methods
The investigation was performed on 26 untreated adult patients with MDS, including 14 with RA, and 12 with RAEB and RAFB-t, who were admitted to our institution. MDS cases were diagnosed from typical clinical and haematological signs, and from cytogenetic findings. Twelve haematologically healthy subjects acted as controls.
Bone marrow smears taken by sternum puncture were air dried, fixed in methanolglacial acid mixture (3:1), and rinsed thoroughly with distilled water. After repeated air drying the preparations were put into 2N formic acid for 10 minutes, rinsed again and impregnated with a mixture of 50% aqueous solution of silver nitrate with gelatin at 68°C for four minutes (after Howell and Black'4 with slight modification7). The preparations were then counterstained with 2% Giemsa for 20 seconds. In each case 50 to 100 blasts, promyelocytes, myelocytes, erythroid elements of the first (Er-I) and second (Er-II) classes (Er-I, pronormoblasts and basophilic normoblasts; Er-II, polychromatic normoblasts), and megakaryocytes were evaluated for the mean numbers of nucleoli and AgNORs. Student's t test was used to compare the patient and control groups. Other statistical analyses, including correlation tests, were done using the computer assisted "HENMA" system.'5
Results
Clinical findings and the results of nucleolus silver staining of bone marrow cells from controls and from MDS patients are presented in table 1 and figure 1.
REFRACTORY ANAEMIA
In controls and patients with RA the fewest numbers of nucleoli were found in blasts and immature erythroid elements. Numbers were intermediate in promyelocytes, myelocytes, and polychromatic normoblasts, and much greater in megakaryocytes. Compared with controls, the mean numbers of nucleoli in blasts and Er-II tended to increase (the difference between indices was insignificant). In Er-I and megakaryocytes the mean numbers of nucleoli in blasts were significantly decreased (p < 0.005 and p < 0.001, respectively).
In controls and patients with RA the maximum numbers of AgNORs per nucleus were found in megakaryocytes, followed by immature erythroid elements (Er-I). 
REFRACTORY ANAEMIAS WITH EXCESS BLASTS
Compared with controls, the patients with RAEB and RAEB-t had a decrease in numbers of nucleoli, not only in immature erythroid elements and megakaryocytes but also in promyelocytes and myelocytes. In addition, the mean numbers of nucleoli were similar in blasts, Er-I, and controls.
Compared with nucleoli counts, the changes of AgNORs in blood forming elements from patients with RAEB and RAEB-t were striking. The mean numbers of AgNORs were noticeably decreased in blasts (p < 0.00 1), promyelocytes (p < 0.05), Er-I (p < 0.001), Er-II (p < 0.002), and megakaryocytes (p < 0.001). The difference between AgNOR counts in blasts, promyelocytes, myelocytes, and polychromatic normoblasts from patients with RAEB and RAEB-t, and those with RA was also significant (p < 0.01 to p < 0.0001). It is also noteworthy that some lower AgNOR counts in the group were detected in patients with RAEB-t whose percentages of blasts in bone marrow and peripheral blood were the highest but haemoglobin concentration and platelet counts were very low.
Additional analysis showed that the AgNOR counts in blasts from patients with RAEB was inversely proportional to those of polychromatic normoblasts (r = -0.81, p < 0.0004) Our findings showed that the AgNOR score in promyelocytes from patients with RA correlated closely with those of blasts (r = 0.7), Er-I (r = 0.86), myelocytes (r = 0.71), and with the content of bone marrow myelocytes (r = 0.5). In addition, the percentage of bone marrow promyelocytes showed a significant correlation with the numbers of bone marrow myelocytes (r = 0.76) and white cell count (r = 0.8). In general these findings indicate a key role of promyelocytes but not blasts (as shown previously in chronic myeloid leukaemia") in RA haematopoiesis. In this context, it is noteworthy that the AgNOR score in promyelocytes was inversely associated with their content in bone marrow (r = -0.65, p < 0.003), suggesting a preservation of some feedback mechanisms at this stage of myelopoiesis. In contrast, the numbers ofAgNORs in Er-I and Er-II were correlated closely with the numbers of these cells in bone marrow (r = 0.61, p < 0.01). Therefore, there may be a disturbance in a similar feedback regulation in RA erythropoiesis.
According to our findings, a possible inhibitory effect on MDS haemopoiesis was present at the level of polychromatic normoblasts and myelocytes from patients with RAEB. This conclusion was based on a strong negative correlation between the AgNOR counts in blasts and polychromatic normoblasts and myelocytes. Compared to blasts, AgNOR counts in RA and RAEB megakaryocytes correlated well with those in polychromatic normoblasts and with the numbers of erythrocytes. In our opinion, this observation suggests that megakaryocytic and erythroid lineages arise from a common precursor and have very similar mechanisms controlling gene expression.
In conclusion, the AgNOR data illustrate the usefulness of this method for detailed evaluation of aspects of haematopoiesis in physiological and pathological conditions. Moreover, there is some indirect evidence that megakaryocytes can participate in a microenvironment and/or stroma support and restoration, including haematopoiesis of patients with RA and RAEB. 
